Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature.

Diotallevi F, Campanati A, Radi G, Brisigotti V, Molinelli E, Brancorsini D, Offidani A.

Dermatol Ther. 2019 Apr 12:e12928. doi: 10.1111/dth.12928. [Epub ahead of print]

PMID:
30980454
2.

Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone.

Molinelli E, Paolinelli M, Campanati A, Brisigotti V, Offidani A.

Expert Opin Drug Metab Toxicol. 2019 May;15(5):367-379. doi: 10.1080/17425255.2019.1600670. Epub 2019 Apr 19. Review.

PMID:
30943794
3.

Familial lupus panniculitis: two cases, same diagnosis, what evolution?

Molinelli E, Campanati A, Brisigotti V, Diotallevi F, Radi G, Racchini S, Giangiacomi M, Offidani A.

G Ital Dermatol Venereol. 2019 Jan 9. doi: 10.23736/S0392-0488.18.06151-5. [Epub ahead of print] No abstract available.

PMID:
30636398
4.

Relapsing acute generalized exanthematous pustolosis: a guess.

Consales V, Campanati A, Bobyr I, Molinelli E, Brisigotti V, Giuliodori K, Ganzetti G, Giangiacomi M, Offidani A.

G Ital Dermatol Venereol. 2019 Feb;154(1):82-83. doi: 10.23736/S0392-0488.16.05292-5. No abstract available.

PMID:
30616333
5.

Dermoscopic features of conjunctival melanocytic lesions.

Brisigotti V, De Blasio S, Cellini A, Ganzetti G, Giangiacomi M, Frongia GB, Campanati A, Offidani A.

G Ital Dermatol Venereol. 2018 Dec;153(6):878-881. doi: 10.23736/S0392-0488.16.05411-0. No abstract available.

PMID:
30518179
6.

Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α Inhibitors.

Campanati A, Molinelli E, Brisigotti V, Offidani A.

Curr Pharm Biotechnol. 2017;18(12):945-963. doi: 10.2174/1389201019666180209121804. Review.

PMID:
29424306
7.

Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma.

Ganzetti G, Sartini D, Campanati A, Rubini C, Molinelli E, Brisigotti V, Cecati M, Pozzi V, Campagna R, Offidani A, Emanuelli M.

Melanoma Res. 2018 Apr;28(2):82-88. doi: 10.1097/CMR.0000000000000430.

PMID:
29420365
8.

Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways.

Molinelli E, Campanati A, Brisigotti V, Offidani A.

Curr Pharm Biotechnol. 2017;18(12):964-978. doi: 10.2174/1389201019666180103140643. Review.

PMID:
29299984
9.

Switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group.

Ganzetti G, Campanati A, Bettacchi A, Brandozzi G, Brisigotti V, Bugatti L, Cataldi I, Filosa G, Giacchetti A, Lemme G, Morresi L, Nicolini M, Postacchini V, Ricotti G, Rosa L, Simonacci M, Offidani A.

G Ital Dermatol Venereol. 2018 Feb;153(1):5-10. doi: 10.23736/S0392-0488.16.05463-8. Epub 2016 Nov 15.

PMID:
27845513
10.

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

Ganzetti G, Campanati A, Santarelli A, Sartini D, Molinelli E, Brisigotti V, Di Ruscio G, Bobyr I, Emanuelli M, Offidani A.

J Int Med Res. 2016 Sep;44(1 suppl):10-14.

11.

Ingenol mebutate in actinic keratosis: a clinical, videodermoscopic and immunohistochemical study.

Bobyr I, Campanati A, Consales V, Martina E, Molinelli E, Diotallevi F, Brisigotti V, Giangiacomi M, Ganzetti G, Giuliodori K, Offidani A.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):260-266. doi: 10.1111/jdv.13831. Epub 2016 Jul 25.

PMID:
27453064
12.

Mycosis Fungoides-like Eruption and Infliximab.

Ganzetti G, Molinelli E, Campanati A, Brisigotti V, Goteri G, Consales V, Racchini S, Bendia E, di Sario A, Benedetti A, Offidani A.

J Clin Gastroenterol. 2016 Aug;50(7):610-1. doi: 10.1097/MCG.0000000000000517. No abstract available.

PMID:
26974764
13.

Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association?

Molinelli E, Giuliodori K, Campanati A, Brisigotti V, Offidani A.

Acta Dermatovenerol Alp Pannonica Adriat. 2015;24(3):55-7.

14.

Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment.

Marconi B, Bobyr I, Campanati A, Molinelli E, Consales V, Brisigotti V, Scarpelli M, Racchini S, Offidani A.

Intractable Rare Dis Res. 2015 Aug;4(3):113-22. doi: 10.5582/irdr.2015.01014. Review.

15.

The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region.

Ganzetti G, Campanati A, Bernardini ML, Bettacchi A, Brandozzi G, Brisigotti V, Cataldi I, Filosa G, Giacchetti A, Lemme G, Morresi L, Nicolini M, Postacchini V, Ricotti G, Rosa L, Simonacci M, Offidani A.

G Ital Dermatol Venereol. 2016 Aug;151(4):340-6. Epub 2015 Jun 19.

PMID:
26091276
16.

Investigating psoriasis awareness among patients in Italy: validation of a questionnaire.

Bardazzi F, Amerio P, Amoruso G, Campanati A, Conti A, De Simone C, Gisondi P, Gualdi G, Guarneri C, Loconsole F, Mazzotta A, Musumeci ML, Odorici G, Piaserico S, Potenza C, Scudeller L; Alphard Study Group.

Eur Rev Med Pharmacol Sci. 2014 Nov;18(22):3435-52.

17.

Periodontal disease: an oral manifestation of psoriasis or an occasional finding?

Ganzetti G, Campanati A, Santarelli A, Pozzi V, Molinelli E, Minnetti I, Brisigotti V, Procaccini M, Emanuelli M, Offidani A.

Drug Dev Res. 2014 Nov;75 Suppl 1:S46-9. doi: 10.1002/ddr.21194.

PMID:
25381976
18.

Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature.

Campanati A, Brisigotti V, Ganzetti G, Molinelli E, Giuliodori K, Consales V, Racchini S, Bendia E, Offidani A.

J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1245-7. doi: 10.1111/jdv.12703. Epub 2014 Sep 8. Review. No abstract available.

PMID:
25200926
19.

Involvement of the oral cavity in psoriasis: results of a clinical study.

Ganzetti G, Campanati A, Santarelli A, Pozzi V, Molinelli E, Minnetti I, Brisigotti V, Procaccini M, Emanuelli M, Offidani A.

Br J Dermatol. 2015 Jan;172(1):282-5. doi: 10.1111/bjd.13201. Epub 2014 Nov 30. No abstract available.

PMID:
25078556
20.

The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients.

Ganzetti G, Campanati A, Scocco V, Brugia M, Tocchini M, Liberati G, Giuliodori K, Brisigotti V, Offidani A.

Acta Derm Venereol. 2014 Nov;94(6):715-7. doi: 10.2340/00015555-1801. No abstract available.

Supplemental Content

Loading ...
Support Center